New BPD predicts lung function at school age: Follow-up study and meta-analysis

Pediatric Pulmonology

Volumn 50, Issue 11, 2015, Pages 1090-1098

  Ronkainen, Eveliina ^a   Dunder, Teija ^a   Peltoniemi, Outi ^a   Kaukola, Tuula ^a   Marttila, Riitta ^a   Hallman, Mikko ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

bronchopulmonary dysplasia; lung function tests; premature birth; pulmonary outcome

Indexed keywords

CORTICOSTEROID; SURFACTANT; LUNG SURFACTANT;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DIFFUSION CAPACITY; LUNG DYSPLASIA; LUNG FUNCTION; MALE; ONSET AGE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; BRONCHOPULMONARY DYSPLASIA; GESTATIONAL AGE; LUNG; META ANALYSIS; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY;

BRONCHOPULMONARY DYSPLASIA; CHILD; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; MALE; PULMONARY SURFACTANTS; SPIROMETRY;

EID: 84945439946     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23153     Document Type: Article

References (31)

1. Jobe AH, Ikegami M,. Lung development and function in preterm infants in the surfactant treatment era. Annu Rev Physiol 2000; 62: 825-846.
2. Northway WH, Jr, Moss RB, Carlisle KB, Parker BR, Popp RL, Pitlick PT, Eichler I, Lamm RL, Brown BW, Jr,. Late pulmonary sequelae of bronchopulmonary dysplasia. N Engl J Med 1990; 323: 1793-1799.
3. Halvorsen T, Skadberg BT, Eide GE, Roksund OD, Carlsen KH, Bakke P,. Pulmonary outcome in adolescents of extreme preterm birth: a regional cohort study. Acta Paediatr 2004; 93: 1294-1300.
4. Doyle LW, Faber B, Callanan C, Freezer N, Ford GW, Davis NM,. Bronchopulmonary dysplasia in very low birth weight subjects and lung function in late adolescence. Pediatrics 2006; 118: 108-113.
5. Wong PM, Lees AN, Louw J, Lee FY, French N, Gain K, Murray CP, Wilson A, Chambers DC,. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J 2008; 32: 321-328.
6. Vollsaeter M, Roksund OD, Eide GE, Markestad T, Halvorsen T,. Lung function after preterm birth: development from mid-childhood to adulthood. Thorax 2013; 68: 767-776.
7. Mieskonen ST, Malmberg LP, Kari MA, Pelkonen AS, Turpeinen MT, Hallman NM, Sovijarvi AR,. Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease. Pediatr Pulmonol 2002; 33: 347-355.
8. Lum S, Kirkby J, Welsh L, Marlow N, Hennessy E, Stocks J,. Nature and severity of lung function abnormalities in extremely pre-term children at 11 years of age. Eur Respir J 2011; 37: 1199-1207.
9. Kaplan E, Bar-Yishay E, Prais D, Klinger G, Mei-Zahav M, Mussaffi H, Steuer G, Hananya S, Matyashuk Y, Gabarra N, et al., Encouraging pulmonary outcome for surviving, neurologically intact, extremely premature infants in the postsurfactant era. Chest 2012; 142: 725-733.
10. Cazzato S, Ridolfi L, Bernardi F, Faldella G, Bertelli L,. Lung function outcome at school age in very low birth weight children. Pediatr Pulmonol 2013; 48: 830-837.
11. Korhonen P, Laitinen J, Hyodynmaa E, Tammela O,. Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era. Acta Paediatr 2004; 93: 316-321.
12. Coalson JJ,. Pathology of bronchopulmonary dysplasia. Semin Perinatol 2006; 30: 179-184.
13. Northway WH, Jr, Rosan RC, Porter DY,. Pulmonary disease following respirator therapy of hyaline-membrane disease. bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-368.
14. Kotecha SJ, Edwards MO, Watkins WJ, Henderson AJ, Paranjothy S, Dunstan FD, Kotecha S,. Effect of preterm birth on later FEV1: a systematic review and meta-A systematic review analysis. Thorax 2013; 68: 760-766.
15. Marttila R, Haataja R, Guttentag S, Hallman M,. Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins. Am J Respir Crit Care Med 2003; 168: 1216-1222.
16. Kaukola T, Tuimala J, Herva R, Kingsmore S, Hallman M,. Cord immunoproteins as predictors of respiratory outcome in preterm infants. Am J Obstet Gynecol 2009; 200: 100 1-8.
17. Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S, Voutilainen R, Hallman M,. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. J Pediatr 2005; 146: 632-637.
18. Peltoniemi OM, Kari MA, Tammela O, Lehtonen L, Marttila R, Halmesmaki E, Jouppila P, Hallman M,. Repeat antenatal betamethasone study group. Randomized trial of a single repeat dose of prenatal betamethasone treatment in imminent preterm birth. Pediatrics 2007; 119: 290-298.
19. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al., Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
20. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al., Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
21. Koillinen H, Wanne O, Niemi V, Laakkonen E,. Terveiden suomalaislasten spirometrian ja uloshengityksen huippuvirtauksen viitearvot. Suom Lääkärilehti 1998; 53: 395-405.
22. Polgar G, Promadhat V,. Pulmonary function testing in children: Techniques and standards. Philadelphia, PA: W. B. Saunders Company; 1971.
23. Roca J, Whipp BJ, Agustí AGN, Anderson SD, Casaburi R, Cotes JE, Donner CF, Estenne M, Folgering H, Higenbottam TW, Killian KJ, Palange P, Patessio A, Prefaut C, Sergysels R, Wagner PD, Weisman I,. ERS Task Force on Standardization of Clinical Exercise Testing. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. Eur Respir J 1997; 10: 2662-2689.
24. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW,. International study of asthma and allergies in childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-491.
25. Jobe AH, Bancalari E,. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
26. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
27. Fawke J, Lum S, Kirkby J, Hennessy E, Marlow N, Rowell V, Thomas S, Stocks J,. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med 2010; 182: 237-245.
28. Joshi S, Powell T, Watkins WJ, Drayton M, Williams EM, Kotecha S,. Exercise-induced bronchoconstriction in school-aged children who had chronic lung disease in infancy. J Pediatr 2013; 162: 813-818.
29. Narayanan M, Beardsmore CS, Owers-Bradley J, Dogaru CM, Mada M, Ball I, Garipov RR, Kuehni CE, Spycher BD, Silverman M,. Catch-up alveolarization in ex-preterm children: evidence from (3) he magnetic resonance. Am J Respir Crit Care Med 2013; 187: 1104-1109.
30. Kinsella JP, Greenough A, Abman SH,. Bronchopulmonary dysplasia. Lancet 2006; 367: 1421-1431.
31. Hacking DF, Gibson AM, Robertson C, Doyle LW,. Victorian Infant Collaborative Study Group (VICS). Respiratory function at age 8-9 after extremely low birthweight or preterm birth in victoria in 1997. Pediatr Pulmonol 2013; 48: 449-455.